PT3801536T - Administração de sepiapterina sem alimentos para utilização num método para aumentar a exposição plasmática a sepiapterina - Google Patents

Administração de sepiapterina sem alimentos para utilização num método para aumentar a exposição plasmática a sepiapterina

Info

Publication number
PT3801536T
PT3801536T PT198118887T PT19811888T PT3801536T PT 3801536 T PT3801536 T PT 3801536T PT 198118887 T PT198118887 T PT 198118887T PT 19811888 T PT19811888 T PT 19811888T PT 3801536 T PT3801536 T PT 3801536T
Authority
PT
Portugal
Prior art keywords
increasing
methods
plasma exposure
sepiapterin
sepiapterin plasma
Prior art date
Application number
PT198118887T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Ptc Therapeutics Mp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Mp Inc filed Critical Ptc Therapeutics Mp Inc
Publication of PT3801536T publication Critical patent/PT3801536T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PT198118887T 2018-05-30 2019-05-30 Administração de sepiapterina sem alimentos para utilização num método para aumentar a exposição plasmática a sepiapterina PT3801536T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862677943P 2018-05-30 2018-05-30
US201862771398P 2018-11-26 2018-11-26
US201962822376P 2019-03-22 2019-03-22
GC201937663 2019-05-28

Publications (1)

Publication Number Publication Date
PT3801536T true PT3801536T (pt) 2024-09-19

Family

ID=68699037

Family Applications (1)

Application Number Title Priority Date Filing Date
PT198118887T PT3801536T (pt) 2018-05-30 2019-05-30 Administração de sepiapterina sem alimentos para utilização num método para aumentar a exposição plasmática a sepiapterina

Country Status (20)

Country Link
US (3) US11617752B2 (cg-RX-API-DMAC7.html)
EP (2) EP3801536B1 (cg-RX-API-DMAC7.html)
JP (2) JP7502197B2 (cg-RX-API-DMAC7.html)
CN (1) CN112703002A (cg-RX-API-DMAC7.html)
AU (2) AU2019277382B2 (cg-RX-API-DMAC7.html)
CA (1) CA3102106A1 (cg-RX-API-DMAC7.html)
DK (1) DK3801536T3 (cg-RX-API-DMAC7.html)
ES (1) ES2986920T3 (cg-RX-API-DMAC7.html)
FI (1) FI3801536T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241213T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068589T2 (cg-RX-API-DMAC7.html)
LT (1) LT3801536T (cg-RX-API-DMAC7.html)
MD (1) MD3801536T2 (cg-RX-API-DMAC7.html)
MX (2) MX2020012979A (cg-RX-API-DMAC7.html)
PL (1) PL3801536T3 (cg-RX-API-DMAC7.html)
PT (1) PT3801536T (cg-RX-API-DMAC7.html)
RS (1) RS65874B1 (cg-RX-API-DMAC7.html)
SI (1) SI3801536T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400430T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019232130A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CA3102105A1 (en) 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンの薬学的に許容される塩
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui
CA3165636A1 (en) * 2020-01-24 2021-07-29 Neil Smith Methods for treating parkinson's disease with sepiapterin
WO2021168206A1 (en) * 2020-02-19 2021-08-26 Musc Foundation For Research Development L-sepiapterin and methods of use for treating diseases and disorders
US12691119B2 (en) 2021-02-09 2026-07-28 Ptc Therapeutics Mp, Inc. Methods for treating covid-19 with sepiapterin
IL305037A (en) * 2021-02-09 2023-10-01 Ptc Therapeutics Mp Inc Methods of treating glioblastomas with spiafatrin
CN120732846A (zh) * 2025-04-09 2025-10-03 中南大学湘雅医院 吲哚乙酸在制备预防或治疗高血压产品中的用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
US5910304A (en) 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
WO1997007236A1 (en) 1995-08-18 1997-02-27 Landry Donald W Detection of organic compounds through regulation of antibody-catalyzed reactions
US6036949A (en) 1998-03-05 2000-03-14 Amarillo Biosciences, Inc. Treatment of fibromyalgia with low doses of interferon
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
WO2005048926A2 (en) 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
CA2545968C (en) 2003-11-17 2010-03-09 Merck Eprova Ag Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
PT3138566T (pt) 2003-11-17 2022-02-02 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
JP5184783B2 (ja) 2003-11-17 2013-04-17 バイオマリン ファーマシューティカル インコーポレイテッド テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法
CN101132776A (zh) 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
US20100130500A1 (en) 2004-12-08 2010-05-27 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
WO2006118322A1 (en) 2005-04-28 2006-11-09 Shiratori Pharmaceutical Co., Ltd. Method for producing hydrazone derivatives
US20080075666A1 (en) 2006-08-25 2008-03-27 Dudley Samuel C Jr Methods and compositions for treating diastolic dysfunction
KR20160065998A (ko) * 2007-04-11 2016-06-09 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
WO2010017570A2 (de) 2008-08-12 2010-02-18 Orpha Swiss Gmbh Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
CA2828685C (en) 2011-03-01 2018-05-29 Rubicon Research Private Limited Stable compositions of tetrahydrobiopterin
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
JP6084967B2 (ja) 2012-05-07 2017-02-22 白鳥製薬株式会社 セピアプテリン及びテトラヒドロラクトイルプテリンの製造法
EP3213062B1 (en) * 2014-10-31 2020-02-12 Children's Medical Center Corporation Methods and assays relating to sepiapterin reductase inhibition
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CN111328414B (zh) * 2017-11-23 2022-09-23 株式会社半导体能源研究所 显示装置及电子设备
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンの薬学的に許容される塩
CA3102105A1 (en) * 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui
IL291565B1 (en) 2019-09-25 2026-04-01 Ptc Therapeutics Inc Method for treating phenylalanine irregularity

Also Published As

Publication number Publication date
EP3801536A1 (en) 2021-04-14
AU2019277382B2 (en) 2025-01-09
EP3801536A4 (en) 2022-03-23
US12329757B2 (en) 2025-06-17
JP2024069192A (ja) 2024-05-21
CN112703002A (zh) 2021-04-23
MX2020012979A (es) 2021-04-29
US20230381181A1 (en) 2023-11-30
DK3801536T3 (da) 2024-08-19
RS65874B1 (sr) 2024-09-30
AU2025200814A1 (en) 2025-02-27
EP3801536B1 (en) 2024-07-17
HUE068589T2 (hu) 2025-01-28
MD3801536T2 (ro) 2024-11-30
PL3801536T3 (pl) 2025-02-03
US20210220363A1 (en) 2021-07-22
JP2021525729A (ja) 2021-09-27
HRP20241213T1 (hr) 2024-11-22
US20260091037A1 (en) 2026-04-02
EP4454704A2 (en) 2024-10-30
FI3801536T3 (fi) 2024-08-29
ES2986920T3 (es) 2024-11-13
EP4454704A3 (en) 2025-01-01
JP7502197B2 (ja) 2024-06-18
MX2024005935A (es) 2024-06-04
JP7841005B2 (ja) 2026-04-06
LT3801536T (lt) 2024-09-25
WO2019232130A1 (en) 2019-12-05
SMT202400430T1 (it) 2024-11-15
AU2019277382A1 (en) 2021-01-21
CA3102106A1 (en) 2019-12-05
US11617752B2 (en) 2023-04-04
SI3801536T1 (sl) 2024-12-31

Similar Documents

Publication Publication Date Title
IL263093B (en) Plasma-based coatings and methods for their preparation and use
IL279632A (en) Compounds and Methods for Reducing LRRK2 Expression
IL268217A (en) exposure device
GB2568748B (en) Projection apparatus
SG11201807876SA (en) Photosensitive film
GB201808433D0 (en) Process
PT3801534T (pt) Tratamento de fenilcetonúria com sepiapterina
IL281207A (en) Metrological device
IL279368A (en) Metrological device
ZA201903649B (en) Treatment for primary biliary cholangitis
GB201807759D0 (en) Process
EP3876307C0 (en) FILM PRODUCTION PROCESS
GB201809199D0 (en) Process
GB201806320D0 (en) Process
IL279285A (en) Industrious electrostatic core
GB201806127D0 (en) Process
GB201506943D0 (en) Apparatus for fused deposition modelling
ZA202005776B (en) Wear-levelling apparatus for cyclones
SG11202100108SA (en) Tie-coat composition
GB201813451D0 (en) Plasma apparatus
GB201810184D0 (en) Process
GB201802710D0 (en) Process
GB201819037D0 (en) Cryo-battery for tokamak
SG10201700216UA (en) Exposure apparatus
PL3519112T3 (pl) Mechanizm regulujący dla układów sortujących